[
    [
        {
            "time": "2021-08-16",
            "original_text": "东吴证券维持金域医学买入评级，2021年中报点评：业绩增长超我们预期，特检业务与数字化转型稳步推进",
            "features": {
                "keywords": [
                    "金域医学",
                    "买入评级",
                    "业绩增长",
                    "特检业务",
                    "数字化转型"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴证券维持金域医学买入评级，2021年中报点评：业绩增长超我们预期，特检业务与数字化转型稳步推进",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-17",
            "original_text": "金域医学上半年净利增超90%，股价却跌近三成 是疫情风口不再还是资本市场脱敏？",
            "features": {
                "keywords": [
                    "金域医学",
                    "净利增长",
                    "股价下跌",
                    "疫情",
                    "资本市场"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学上半年净利增超90%，股价却跌近三成 是疫情风口不再还是资本市场脱敏？",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-18",
            "original_text": "ST三五：拟与买方金域医学签订办公楼购买意向书",
            "features": {
                "keywords": [
                    "ST三五",
                    "金域医学",
                    "办公楼购买",
                    "意向书"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "房地产",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "ST三五：拟与买方金域医学签订办公楼购买意向书",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-08-19",
            "original_text": "金域医学(603882)：核酸检测持续放量 常规业务增长超预期",
            "features": {
                "keywords": [
                    "金域医学",
                    "核酸检测",
                    "常规业务",
                    "增长超预期"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "金域医学(603882)：核酸检测持续放量 常规业务增长超预期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-20",
            "original_text": "华金证券下调金域医学评级至增持：常规业务快速恢复，新冠业务保持高弹性 投资评级恶化",
            "features": {
                "keywords": [
                    "华金证券",
                    "金域医学",
                    "评级下调",
                    "常规业务",
                    "新冠业务"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华金证券下调金域医学评级至增持：常规业务快速恢复，新冠业务保持高弹性 投资评级恶化",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-21",
            "original_text": "西南证券维持金域医学买入评级：Q2业绩超预期，常规业务有望进一步恢复",
            "features": {
                "keywords": [
                    "西南证券",
                    "金域医学",
                    "买入评级",
                    "Q2业绩",
                    "常规业务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "西南证券维持金域医学买入评级：Q2业绩超预期，常规业务有望进一步恢复",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-22",
            "original_text": "金域医学发布中报：扣非净利同增91.43%，累计新冠核酸检测9900万人次",
            "features": {
                "keywords": [
                    "金域医学",
                    "中报",
                    "扣非净利",
                    "新冠核酸检测"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "金域医学发布中报：扣非净利同增91.43%，累计新冠核酸检测9900万人次",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]